首页> 外国专利> DRUG COMPOSITION HAVING PREVENTING AND REMEDYING ACTION ON ROTAVIRUS INFECTIOUS DISEASE

DRUG COMPOSITION HAVING PREVENTING AND REMEDYING ACTION ON ROTAVIRUS INFECTIOUS DISEASE

机译:药物组合物具有预防和补救轮状病毒感染性疾病的作用

摘要

PURPOSE:A preventive and remedy for a rotavirus infections diesease, having neutralizing activity on rotavirus and high safety, comprising a monomer IgA as a main ingredient. CONSTITUTION:An immunoglobulin comprising a monomer IgA as a main ingredient is collected from the serum, plasma, and placental blood of humal and mammals as a raw material, and used for preventing and remedying rotavirus. The raw material is purified by salting out method, ion exchange chromatography, gel filtration, affinity chromatography, etc., so that the content of IgG causing allergic reactions like anaphylaxis is =10wt%, preferably a mall amount as less as possible. The obtained monomer IgA exhibits strong neutralizing acrivity against rotavirus, and also suppresses the propagation of rotarirus in an animal experiment. In pharmaceutical preparation, after being converted into a common oral drug, it is advantageously subjected to enteric coating. The dosage is 10-5,000mg/day as monomer IgA.
机译:目的:一种轮状病毒感染病的预防和治疗药,对轮状病毒具有中和活性,具有很高的安全性,以单体IgA为主要成分。组成:以人IgA单体为主要成分的免疫球蛋白,是从人和哺乳动物的血清,血浆和胎盘血中采集的,以预防和治疗轮状病毒为原料。通过盐析法,离子交换色谱法,凝胶过滤,亲和色谱法等纯化原料,使得引起过敏反应如过敏反应的IgG的含量≤10wt%,优选尽可能少。所获得的单体IgA在动物实验中表现出对轮状病毒的强中和力,并且还抑制了轮状病毒的繁殖。在药物制剂中,在转化成普通的口服药物后,有利地进行肠溶衣。剂量为10-5,000mg /天,作为单体IgA。

著录项

  • 公开/公告号JPS6355494B2

    专利类型

  • 公开/公告日1988-11-02

    原文格式PDF

  • 申请/专利权人 MOCHIDA PHARM CO LTD;

    申请/专利号JP19800136268

  • 发明设计人 FUJII YOSHITOMO;

    申请日1980-09-30

  • 分类号A61K39/395;

  • 国家 JP

  • 入库时间 2022-08-22 07:02:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号